Infectious Disease Control APAC News & Press Release Distribution

Infectious Disease Control

All
Global

Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vacci...

2021-10-27 10:24 4803

Josip Heit comments on the current situation of dealing with the coronavirus

STOCKHOLM, Oct. 25, 2021 /PRNewswire/ -- GSB Gold Standard Pay KB Sweden: In the intensive care units of the Federal Republic ofGermany, more people will probably have to be treated with Covid-19 again in the near future; as has been known for some time, this is due to the cold season.

2021-10-25 15:00 3683

Josip Heit comments on the current situation of dealing with the coronavirus

/C O R R E C T I O N -- Korean Ginseng Research Institute/

We are advised by the client that there are several changes in the release content. The complete, corrected version of the news release issued on 21-Oct-2021 by Korean Ginseng Research Institute over PR Newswire is as follows: Red Ginseng's possible Vaccine Adjuvant Effect gave out from Korean Gin...

2021-10-22 17:20 4701

/C O R R E C T I O N -- Korean Ginseng Research Institute/

In the news release, Korean Ginseng Research Institute Announces potential COVID-19 Vaccine Adjuvant Effect of Red Ginseng, issued20-Oct-2021 by Korean Ginseng Research Institute over PR Newswire, we are advised by the company that the headline, should read "Korean Ginseng Research Institute A...

2021-10-22 16:28 7056

Educating children about good hygiene is key to helping reduce future health threats

LONDON, Oct. 22, 2021 /PRNewswire/ -- The COVID-19 pandemic has heightened awareness globally of the role that hygiene measures like handwashing can play in infection prevention. Handwashing at high-risk moments is a proven and cost-effective way of reducing common infections by up to 50%. Resea...

2021-10-22 14:01 3464

Aero HygenX Partners with Ethiopian Airlines for Deployment of Autonomous UV-C Disinfecting Solution

* With hygiene in sharp focus, industry support for Aero HygenX continues to grow * Chemical-free disinfection via UV-C light offers a safer work environment for staff and is gentler on aircraft interiors * A global problem requires global solutions: It is the intention of Aero HygenX to ...

2021-10-21 21:57 2915

INOVIO Announces Collaboration with Colombia; Memorandum of Understanding Focuses on Protecting Against COVID-19 and Supporting Broader Health Preparedness Initiatives

Memorandum of Understanding builds on recent regulatory authorization from INVIMAto conduct INNOVATE Phase 3 trial for INO-4800, INOVIO's COVID-19 vaccine candidate,in Colombia Colombia authorization augments recent regulatory authorizations from Brazil, the Philippines and Mexico to commence it...

2021-10-21 20:00 4549

INOVIO Announces Collaboration with Colombia; Memorandum of Understanding Focuses on Protecting Against COVID-19 and Supporting Broader Health Preparedness Initiatives

BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine

VANCOUVER, BC, Oct. 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA:5LB), (OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that it has filed with the United States Patent & Trademark Office ("USPTO") a provisional patent application for its haptenized viral antigen va...

2021-10-20 21:24 5654

Bill & Melinda Gates Foundation Commits up to $120 Million to Accelerate Access to COVID-19 Drug for Lower-Income Countries, Calls on Other Donors to Mobilize Resources

Financial commitment aims to secure dedicated, low-cost supply of molnupiravir, if the drug is authorized by regulators; builds on long-term efforts to increase access to tests, treatments, vaccines SEATTLE, Oct. 20, 2021 /PRNewswire/ -- The Bill & Melinda Gates Foundation announced today a comm...

2021-10-20 13:29 3212

CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections

LAUSANNE, Switzerland and BOSTON, Oct. 19, 2021 /PRNewswire/ -- Debiopharm ( www.debiopharm.com ), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453...

2021-10-19 09:00 2340

Novavax to Participate in World Vaccine Congress Europe

GAITHERSBURG, Md., Oct. 16, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a...

2021-10-16 04:39 5818

Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine

TAIPEI, Oct. 15, 2021 /PRNewswire/ -- The Lancet Respiratory Medicine , one of the world's best-known peer-reviewed medical journals has published Medigen Vaccine Biologics (...

2021-10-15 18:36 5440

Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effective Universal Booster For Vaccines Produced By AstraZeneca, Sinopharm, Moderna And Cansino Inducing Strong Immune Response And Showing High Safety Profile. Combination Of AstraZeneca And Sputnik Light Vaccines Showed High Immunogenicity Results.

* One-shot Sputnik Light is the first component of the Sputnik V vaccine, the world's first registered vaccine against coronavirus. Sputnik V pioneered the heterogeneous boosting approach (a "vaccine cocktail" using human adenovirus serotype 26 as the first component and human adenovirus seroty...

2021-10-15 05:26 2678

More community healthcare needed in COVID-19 planning as chronic disease rates pressure hospitals

* Allied health experts call for more community-based care models to cope with COVID surge * 'Long COVID' shown to affect one in four people who catch the virus, leading to an increase in chronic disease sufferers and the need for more rehabilitation services. The UK now has two million cases...

2021-10-13 05:00 2464

More community healthcare needed in COVID-19 planning as chronic disease rates pressure hospitals

1 ... 19 20 21 2223